Image

Herniorrhaphy for Postoperative Pain

Recruiting
18 - 75 years of age
Both
Phase 3

Powered by AI

Overview

Subjects receive either CPL-01, positive control, or negative control after herniorrhaphy and are then followed.

Eligibility

Inclusion Criteria:

  • Able to sign Informed Consent
  • Scheduled to have inguinal hernia repair
  • Be a reasonably healthy adult 18 - 75 years of age
  • Body mass index ≤ 39 kg/m2
  • If biologically female, not pregnant or planning to become pregnant
  • If biologically male, using acceptable birth control
  • Be willing and able to complete study procedures

Exclusion Criteria:

  • Previously inguinal herniorrhaphy
  • Concurrent painful condition that may require analgesic treatment
  • History or clinical manifestation of significant medical, neuropsychiatric, or other condition, significant abnormal clinical laboratory test value, or known bleeding abnormality that could preclude or impair study participation
  • Clinically significant existing arrhythmia, bundle branch block or abnormal ECG, myocardial infarction, or coronary arterial bypass graft surgery within the prior 12 months
  • History of malignant hyperthermia or glucose-6-phosphate dehydrogenase deficiency.
  • Impaired liver function (e.g., alanine aminotransferase [ALT] > 3 × upper limit of normal [ULN] or total bilirubin > 2 × ULN), active hepatic disease, or cirrhosis.
  • Impaired renal function (e.g., creatinine > 1.5 × ULN).
  • Malignancy in the past year
  • Known or suspected daily use of opioids for 7 or more consecutive days within the previous 6 months.

Study details

Hernia, Inguinal

NCT05813847

Cali Pharmaceuticals LLC

15 February 2024

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.